Abstract

Obesity is a metabolic disease which has now reached epidemic proportions, becoming a major health, social, and economic problem worldwide. Untreated obesity is associated with decreased quality of life and is a significant risk factor for the development of other serious health problems, such as diabetes and cardiovascular diseases. For this reason, new approaches to prevent excess body mass and to support its reduction if necessary are being examined. Catechins extracted from green tea – especially epigallocatechin gallate (EGCG) – are one of the most widely investigated biologically active substances. In addition to the antioxidant, anti-inflammatory, and anticarcinogenic properties of the catechins, they also exhibit a role in maintaining normal fat mass and body mass. There are numerous research studies showing that regular green tea consumption is associated with lower body mass, BMI, and waist circumference. In vitro and animal experiments confirm beneficial effects of catechins on the energetic metabolism. These compounds lower lipid and carbohydrates absorption in the intestine. Additionally, they affect the energetic metabolism, lowering the rate of lipogenesis and adipogenesis, while stimulating lipolysis and fatty acid oxidation, and increasing energy expenditure. Moreover, it has been established that green tea catechins have an effect on the glucose uptake in the insulin-dependent manner – by GLUT4. The aim of the following paper was to review and summarize the literature data concerning the role of green tea catechins in the prevention and treatment of obesity.

References

• 1. Amiot M.J., Riva C., Vinet A.: Effects of dietary polyphenols onmetabolic syndrome features in humans: A systematic review. Obes.Rev., 2016; 17: 573-586
  Google Scholar
• 2. Basu A., Sanchez K., Leyva M.J., Wu M., Betts N.M., Aston C.E.,Lyons T.J.: Green tea supplementation affects body weight, lipids,and lipid peroxidation in obese subjects with metabolic syndrome.J. Am. Coll. Nutr., 2010; 29: 31-40
  Google Scholar
• 3. Bose M., Lambert J.D., Ju J., Reuhl K.R., Shapses S.A., Yang C.S.: Themajor green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibitsobesity, metabolic syndrome and fatty liver disease in high-fat-fedmice. J. Nutr., 2008; 138: 1677-1683
  Google Scholar
• 4. Chen I.J., Liu C.Y., Chiu J.P., Hsu C.H.: Therapeutic effect of highdosegreen tea extract on weight reduction: A randomized, doubleblind,placebo-controlled clinical trial. Clin. Nutr., 2016; 35: 592-599
  Google Scholar
• 5. De Pergola G., Silvestris F.: Obesity as a major risk factor for cancer.J. Obes., 2013; 2013: 291546
  Google Scholar
• 6. El Sebaei M., El-Bahr S.M., Al-Nazawi M., Abdel-Raheem S.: Effectsof green tea on adipose gene expression, hepatic antioxidants andlipid profile in obese male rats. Int. J. Pharmacol., 2019; 15: 542-548
  Google Scholar
• 7. Friedrich M., Petzke K.J., Raederstorff D., Wolfram S., Klaus S.:Acute effects of epigallocatechin gallate from green tea on oxidationand tissue incorporation of dietary lipids in mice fed a high-fatdiet. Int. J. Obes., 2012; 36: 735-743
  Google Scholar
• 8. Fukino Y., Ikeda A., Maruyama K., Aoki N., Okubo T., Iso H.: Randomizedcontrolled trial for an effect of green tea-extract powdersupplementation on glucose abnormalities. Eur. J. Clin. Nutr., 2008;62: 953-960
  Google Scholar
• 9. González-Sarrías A., Combet E., Pinto P., Mena P., Dall’Asta M., Garcia-Aloy M., Rodríguez-Mateos A., Gibney E.R., Dumont J., MassaroM., Sánchez-Meca J., Morand C., García-Conesa M.T.: A systematicreview and meta-analysis of the effects of flavanol-containing tea,cocoa and apple products on body composition and blood lipids:Exploring the factors responsible for variability in their efficacy.Nutrients, 2017; 9: 746
  Google Scholar
• 10. Grove K.A., Sae-tan S., Kennett M.J., Lambert J.D.: (-)-Epigallocatechin-3-gallate inhibits pancreatic lipase and reduces bodyweight gain in high fat-fed obese mice. Obesity, 2012; 20: 2311-2313
  Google Scholar
• 11. Ikeda I., Tsuda K., Suzuki Y., Kobayashi M., Unno T., TomoyoriH., Goto H., Kawata Y., Imaizumi K., Nozawa A., Kakuda T.: Teacatechins with a galloyl moiety suppress postprandial hypertriacylglycerolemiaby delaying lymphatic transport of dietary fat inrats. J. Nutr., 2005; 135: 155-159
  Google Scholar
• 12. Iso H., Date C., Wakai K., Fukui M., Tamakoshi A., JACC StudyGroup: The relationship between green tea and total caffeine intakeand risk for self-reported type 2 diabetes among Japanese adults.Ann. Intern. Med., 2006; 144: 554-562
  Google Scholar
• 13. Jura M., Jarosławska J., Chu D.T., Kozak L.P.: Mest and Sfrp5are biomarkers for healthy adipose tissue. Biochimie, 2016; 124:124-133
  Google Scholar
• 14. Kamiyama O., Sanae F., Ikeda K., Higashi Y., Minami Y., AsanoN., Adachi I., Kato A.: In vitro inhibition of α-glucosidases and glycogenphosphorylase by catechin gallate in green tea. Food Chem.,2010; 122: 1061-1066
  Google Scholar
• 15. Kapoor M.P., Sugita M., Fukuzawa Y., Okubo T.: Physiologicaleffects of epigallocatechin-3-gallate (EGCG) on energy expenditurefor prospective fat oxidation in humans: A systematic review andmeta-analysis. J. Nutr. Biochem., 2017; 43: 1-10
  Google Scholar
• 16. Kim H.J., Jeon S.M., Lee M.K., Jung U.J., Shin S.K., Choi M.S.:Antilipogenic effect of green tea extract in C57BL/6J-Lep ob/obmice. Phytother. Res., 2009; 23: 467-471
  Google Scholar
• 17. Klaus S., Pültz S., Thöne-Reineke C., Wolfram S.: Epigallocatechingallate attenuates diet-induced obesity in mice by decreasingenergy absorption and increasing fat oxidation. Int. J. Obes.,2005; 29: 615-623
  Google Scholar
• 18. Lee M.S., Kim C.T., Kim I.H., Kim Y.: Inhibitory effects of greentea catechin on the lipid accumulation in 3T3-L1 adipocytes. Phytopher.Res., 2009; 23: 1088-1091
  Google Scholar
• 19. Lee M.S., Kim C.T., Kim Y.: Green tea (-)-epigallocatechin-3-gallatereduces body weight with regulation of multiple genes expressionin adipose tissue of diet-induced obese mice. Ann. Nutr.Metab., 2009; 54: 151-157
  Google Scholar
• 20. Lee W., Lee D., Han E., Choi J.: Intake of green tea products andobesity in nondiabetic overweight and obese females: A systematicreview and meta-analysis. J. Funct. Foods, 2019; 58: 330-337
  Google Scholar
• 21. Liu K., Zhou R., Wang B., Chen K., Shi L.Y., Zhu J.D., Mi M.T.Effect of green tea on glucose control and insulin sensitivity: Ameta-analysis of 17 randomized controlled trials. Am. J. Clin. Nutr.,2013; 98: 340-348
  Google Scholar
• 22. Lu H., Meng X., Yang C.S.: Enzymology of methylation oftea catechins and inhibition of catechol-O-methyltransferase by(−)-epigallocatechin gallate. Drug Metab. Dispos., 2003; 31: 572-579
  Google Scholar
• 23. Maki K.C., Reeves M.S., Farmer M., Yasunaga K., Matsuo N.,Katsuragi Y., Komikado M., Tokimitsu I., Wilder D., Jones F., BlumbergJ.B., Cartwright Y.: Green tea catechin consumption enhancesexercise-induced abdominal fat loss in overweight and obeseadults. J. Nutr., 2009; 139: 264-270
  Google Scholar
• 24. Moon H.S., Chung C.S., Lee H.G., Kim T.G., Choi Y.J., Cho C.S.:Inhibitory effect of (-)-epigallocatechin-3-gallate on lipid accumulationof 3T3-L1 cells. Obesity, 2007; 15: 2571-2582
  Google Scholar
• 25. Nagao T., Komine Y., Soga S., Meguro S., Hase T., Tanaka Y.,Tokimitsu I.: Ingestion of a tea rich in catechins leads to a reductionin body fat and malondialdehyde-modified LDL in men. Am.J. Clin. Nutr., 2005; 81: 122-129
  Google Scholar
• 26. Ota N., Soga S., Shimotoyodome A., Inaba M., Murase T., TokimitsuI.: Effects of combination of regular exercise and tea catechinsintake on energy expenditure in humans. J. Health Sci., 2005; 51:233-236
  Google Scholar
• 27. Pozza C., Isidori A.M.: What’s behind the obesity epidemic. W:Imaging in bariatric surgery, red.: A. Laghi, M. Rengo. Springer,Cham 2018, 1-8
  Google Scholar
• 28. Rahim A.T., Takahashi Y., Yamaki K.: Mode of pancreatic lipaseinhibition activity in vitro by some flavonoids and non-flavonoidpolyphenols. Food Res. Int., 2015; 75: 289-294
  Google Scholar
• 29. Sae-Tan S., Grove K.A., Kennett M.J., Lambert J.D.: (-)-Epigallocatechin-3-gallate increases the expression of genes relatedto fat oxidation in the skeletal muscle of high fat-fed mice. FoodFunct., 2011; 2: 111-116
  Google Scholar
• 30. Shishikura Y., Khokhar S., Murray B.S.: Effect of tea polyphenolson emulsification of olive oil in a small intestine model system.J. Agric. Food Chem., 2006; 54: 1906-1913
  Google Scholar
• 31. Shrestha S., Ehlers S.J., Lee J.Y., Fernandez M.L., Koo S.I.: Dietarygreen tea extract lowers plasma and hepatic triglycerides and decreases the expression of sterol regulatory element-bindingprotein-1c mRNA and its responsive genes in fructose-fed, ovariectomizedrats. J. Nutr., 2009; 139: 640-645
  Google Scholar
• 32. Takahashi M., Ozaki M., Tsubosaka M., Kim H.K., Sasaki H.,Matsui Y., Hibi M., Osaki N., Miyashita M., Shibata S.: Effects of timingof acute and consecutive catechin ingestion on postprandialglucose metabolism in mice and humans. Nutrients, 2020; 12: 565
  Google Scholar
• 33. Tian C., Ye X., Zhang R., Long J., Ren W., Ding S., Liao D., Jin X.,Wu H., Xu S., Ying C.: Green tea polyphenols reduced fat depositsin high fat-fed rats via erk1/2-PPARγ-adiponectin pathway. PLoSOne, 2013; 8: e53796
  Google Scholar
• 34. Ueda-Wakagi M., Nagayasu H., Yamashita Y., Ashida A.H.: Greentea ameliorates hyperglycemia by promoting the translocation ofglucose transporter 4 in the skeletal muscle of diabetic rodents.Int. J. Mol. Sci., 2019; 20: 2436
  Google Scholar
• 35. Venables M.C., Hulston C.J., Cox H.R., Jeukendrup A.E.: Greentea extract ingestion, fat oxidation, and glucose tolerance inhealthy humans. Am. J. Clin. Nutr., 2008; 87: 778-784
  Google Scholar
• 36. Vieira Senger A.E., Schwanke C.H.A., Gomes I., Valle GottliebM.G.: Effect of green tea (Camellia sinensis) consumption on thecomponents of metabolic syndrome in elderly. J. Nutr. Health Aging,2012; 16: 738-742
  Google Scholar
• 37. Voigt A., Ribot J., Sabater A.G., Palou A., Bonet M.L., Klaus S.:Identification of Mest/Peg1 gene expression as a predictive biomarkerof adipose tissue expansion sensitive to dietary anti-obesityinterventions. Genes Nutr., 2015; 10: 27
  Google Scholar
• 38. Wu C.H., Lu F.H., Chang C.S., Chang T.C., Wang R.H., Chang C.J.:Relationship among habitual tea consumption, percent body fat,and body fat distribution. Obes. Res., 2003; 11: 1088-1095
  Google Scholar
• 39. Yan S., Shao H., Zhou Z., Wang Q., Zhao L.., Yang X.: Non-extractablepolyphenols of green tea and their antioxidant, anti-α-glucosidase capacity, and release during in vitro digestion. J. Funct.Foods, 2018; 42: 129-136
  Google Scholar
• 40. Yang Z., Zhu M.Z., Zhang Y.B., Wen B.B., An H.M., Ou X.C., XiongY.F., Lin H.Y., Liu Z.H., Huang J.A.: Coadministration of epigallocatechin‐3‐gallate (EGCG) and caffeine in low dose ameliorates obesityand nonalcoholic fatty liver disease in obese rats. Phytother.Res. 2019; 33: 1019-1026
  Google Scholar
• 41. Yilmazer-Musa M., Griffith A.M., Michels A.J., Schneider E., FreiB.: Grape seed and tea extracts and catechin 3-gallates are potentinhibitors of α-amylase and α-glucosidase activity. J. Agric. FoodChem., 2012; 60: 8924-8929
  Google Scholar
• 42. Zhan W., Liu Y., Li D., Liu Y.: Advancing insights on the anti-obesitybiochemical mechanism of (-)-epigallocatechin gallate (EGCG)by inhibiting α-amylase activity. RSC Adv., 2016; 6: 96918-96927
  Google Scholar
• 43. Zheng X.X., Xu Y.L., Li S.H., Hui R., Wu Y.J., Huang X.H.: Effectsof green tea catechins with or without caffeine on glycemic controlin adults: A meta-analysis of randomized controlled trials. Am. J.Clin. Nutr., 2013; 97: 750-762
  Google Scholar

Full text